Review



reference strain atcc 17978  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC reference strain atcc 17978
    Reference Strain Atcc 17978, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2517 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference strain atcc 17978/product/ATCC
    Average 99 stars, based on 2517 article reviews
    reference strain atcc 17978 - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    99
    ATCC reference strain atcc 17978
    Reference Strain Atcc 17978, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference strain atcc 17978/product/ATCC
    Average 99 stars, based on 1 article reviews
    reference strain atcc 17978 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC reference strain a baumannii atcc 17978
    Reference Strain A Baumannii Atcc 17978, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference strain a baumannii atcc 17978/product/ATCC
    Average 99 stars, based on 1 article reviews
    reference strain a baumannii atcc 17978 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC reference strain a baumannii atcc
    Antibacterial and anti-persister activity of the designed AMP. A Broth microdilution assay illustrating the antibacterial activity of the designed antimicrobial peptide and colistin against A. <t>baumannii</t> ATCC 17,978. The top two rows represent the growth control wells (no antimicrobial treatment). The next three rows correspond to serial twofold dilutions of colistin, and the three rows below correspond to serial twofold dilutions of the designed peptide. Wells showing no visible turbidity indicate inhibition of bacterial growth at the respective concentration. B Growth curves of control (no antimicrobial treatment), peptide-treated, and colistin-treated samples over 24 h. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001. Data are presented as mean ± standard deviation (SD) of three independent experiments ( n = 3).
    Reference Strain A Baumannii Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference strain a baumannii atcc/product/ATCC
    Average 99 stars, based on 1 article reviews
    reference strain a baumannii atcc - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC a baumannii atcc 17978 reference strain
    Antibacterial and anti-persister activity of the designed AMP. A Broth microdilution assay illustrating the antibacterial activity of the designed antimicrobial peptide and colistin against A. <t>baumannii</t> ATCC 17,978. The top two rows represent the growth control wells (no antimicrobial treatment). The next three rows correspond to serial twofold dilutions of colistin, and the three rows below correspond to serial twofold dilutions of the designed peptide. Wells showing no visible turbidity indicate inhibition of bacterial growth at the respective concentration. B Growth curves of control (no antimicrobial treatment), peptide-treated, and colistin-treated samples over 24 h. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001. Data are presented as mean ± standard deviation (SD) of three independent experiments ( n = 3).
    A Baumannii Atcc 17978 Reference Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a baumannii atcc 17978 reference strain/product/ATCC
    Average 99 stars, based on 1 article reviews
    a baumannii atcc 17978 reference strain - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC a baumannii reference strain atcc 17978
    Antibacterial and anti-persister activity of the designed AMP. A Broth microdilution assay illustrating the antibacterial activity of the designed antimicrobial peptide and colistin against A. <t>baumannii</t> ATCC 17,978. The top two rows represent the growth control wells (no antimicrobial treatment). The next three rows correspond to serial twofold dilutions of colistin, and the three rows below correspond to serial twofold dilutions of the designed peptide. Wells showing no visible turbidity indicate inhibition of bacterial growth at the respective concentration. B Growth curves of control (no antimicrobial treatment), peptide-treated, and colistin-treated samples over 24 h. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001. Data are presented as mean ± standard deviation (SD) of three independent experiments ( n = 3).
    A Baumannii Reference Strain Atcc 17978, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a baumannii reference strain atcc 17978/product/ATCC
    Average 99 stars, based on 1 article reviews
    a baumannii reference strain atcc 17978 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    ATCC reference strain ab atcc 17978
    Antibacterial and anti-persister activity of the designed AMP. A Broth microdilution assay illustrating the antibacterial activity of the designed antimicrobial peptide and colistin against A. <t>baumannii</t> ATCC 17,978. The top two rows represent the growth control wells (no antimicrobial treatment). The next three rows correspond to serial twofold dilutions of colistin, and the three rows below correspond to serial twofold dilutions of the designed peptide. Wells showing no visible turbidity indicate inhibition of bacterial growth at the respective concentration. B Growth curves of control (no antimicrobial treatment), peptide-treated, and colistin-treated samples over 24 h. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001. Data are presented as mean ± standard deviation (SD) of three independent experiments ( n = 3).
    Reference Strain Ab Atcc 17978, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference strain ab atcc 17978/product/ATCC
    Average 99 stars, based on 1 article reviews
    reference strain ab atcc 17978 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Antibacterial and anti-persister activity of the designed AMP. A Broth microdilution assay illustrating the antibacterial activity of the designed antimicrobial peptide and colistin against A. baumannii ATCC 17,978. The top two rows represent the growth control wells (no antimicrobial treatment). The next three rows correspond to serial twofold dilutions of colistin, and the three rows below correspond to serial twofold dilutions of the designed peptide. Wells showing no visible turbidity indicate inhibition of bacterial growth at the respective concentration. B Growth curves of control (no antimicrobial treatment), peptide-treated, and colistin-treated samples over 24 h. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001. Data are presented as mean ± standard deviation (SD) of three independent experiments ( n = 3).

    Journal: Scientific Reports

    Article Title: In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells

    doi: 10.1038/s41598-025-33137-w

    Figure Lengend Snippet: Antibacterial and anti-persister activity of the designed AMP. A Broth microdilution assay illustrating the antibacterial activity of the designed antimicrobial peptide and colistin against A. baumannii ATCC 17,978. The top two rows represent the growth control wells (no antimicrobial treatment). The next three rows correspond to serial twofold dilutions of colistin, and the three rows below correspond to serial twofold dilutions of the designed peptide. Wells showing no visible turbidity indicate inhibition of bacterial growth at the respective concentration. B Growth curves of control (no antimicrobial treatment), peptide-treated, and colistin-treated samples over 24 h. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001. Data are presented as mean ± standard deviation (SD) of three independent experiments ( n = 3).

    Article Snippet: The reference strain A. baumannii ATCC 17,978, originally isolated from a neonatal meningitis case, was used in this study.

    Techniques: Activity Assay, Microdilution Assay, Control, Inhibition, Concentration Assay, Standard Deviation

    Representative agar plates showing colony growth of A. baumannii under different treatment conditions. Bacterial survival was evaluated following exposure to the designed AMP and colistin. (A) the untreated control showing dense colony growth, (B) cultures treated with colistin, and (C) cultures treated with the designed peptide. A marked reduction in colony numbers was observed in treated samples compared with the control.

    Journal: Scientific Reports

    Article Title: In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells

    doi: 10.1038/s41598-025-33137-w

    Figure Lengend Snippet: Representative agar plates showing colony growth of A. baumannii under different treatment conditions. Bacterial survival was evaluated following exposure to the designed AMP and colistin. (A) the untreated control showing dense colony growth, (B) cultures treated with colistin, and (C) cultures treated with the designed peptide. A marked reduction in colony numbers was observed in treated samples compared with the control.

    Article Snippet: The reference strain A. baumannii ATCC 17,978, originally isolated from a neonatal meningitis case, was used in this study.

    Techniques: Control

    Antibacterial activity and cytotoxicity assessment in HT29 epithelial cell cultures. A Colony enumeration of A. baumannii after treatment with the designed peptide at 32 and 64 µg/mL compared with untreated control samples, demonstrating dose-dependent antibacterial effects in infected HT29 cells. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: * p < 0.05. B Cytotoxicity profile of the peptide on HT29 cells at the same concentrations, showing the percentage of viable cells and indicating a tolerable cytotoxicity range.

    Journal: Scientific Reports

    Article Title: In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells

    doi: 10.1038/s41598-025-33137-w

    Figure Lengend Snippet: Antibacterial activity and cytotoxicity assessment in HT29 epithelial cell cultures. A Colony enumeration of A. baumannii after treatment with the designed peptide at 32 and 64 µg/mL compared with untreated control samples, demonstrating dose-dependent antibacterial effects in infected HT29 cells. Statistical significance vs. control was determined by Tukey’s multiple comparisons test: * p < 0.05. B Cytotoxicity profile of the peptide on HT29 cells at the same concentrations, showing the percentage of viable cells and indicating a tolerable cytotoxicity range.

    Article Snippet: The reference strain A. baumannii ATCC 17,978, originally isolated from a neonatal meningitis case, was used in this study.

    Techniques: Activity Assay, Control, Infection

    Time-dependent inhibitory effect of the designed AMP on A. baumannii biofilm formation. No significant reduction in biofilm formation was observed at early time points (1 h and 4 h). However, treatment with the peptide (64 µg/mL) significantly reduced biofilm biomass after 24 h, as indicated by a decrease in mean OD 550 from 0.71 to 0.49 ( p = 0.0056).

    Journal: Scientific Reports

    Article Title: In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells

    doi: 10.1038/s41598-025-33137-w

    Figure Lengend Snippet: Time-dependent inhibitory effect of the designed AMP on A. baumannii biofilm formation. No significant reduction in biofilm formation was observed at early time points (1 h and 4 h). However, treatment with the peptide (64 µg/mL) significantly reduced biofilm biomass after 24 h, as indicated by a decrease in mean OD 550 from 0.71 to 0.49 ( p = 0.0056).

    Article Snippet: The reference strain A. baumannii ATCC 17,978, originally isolated from a neonatal meningitis case, was used in this study.

    Techniques:

    Expression of target genes in A. baumannii following peptide treatment. Relative expression levels of pmr B and las I were measured at 1, 4, and 24 h after exposure to the designed peptide, compared with untreated control samples. 16 S rRNA was used as the internal reference for normalization, and fold changes are presented to illustrate the peptide-induced stress response. Statistical significance was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001.

    Journal: Scientific Reports

    Article Title: In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells

    doi: 10.1038/s41598-025-33137-w

    Figure Lengend Snippet: Expression of target genes in A. baumannii following peptide treatment. Relative expression levels of pmr B and las I were measured at 1, 4, and 24 h after exposure to the designed peptide, compared with untreated control samples. 16 S rRNA was used as the internal reference for normalization, and fold changes are presented to illustrate the peptide-induced stress response. Statistical significance was determined by Tukey’s multiple comparisons test: ** p < 0.01, **** p < 0.0001.

    Article Snippet: The reference strain A. baumannii ATCC 17,978, originally isolated from a neonatal meningitis case, was used in this study.

    Techniques: Expressing, Control